Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Apricus Biosciences grants Bracco rights to market Vitaros in Italy

Jan. 3, 2011

Isotechnika and Paladin seek Canadian marketing approval for Voclera

Dec. 22, 2010

Health Canada approves velaglucerase alfa for type I Gaucher's disease

Dec. 2, 2010

Health Canada approves Allergan's Restasis for dry eye disease

Nov. 26, 2010

Health Canada approves Vitaros as first-line therapy for erectile dysfunction

Nov. 16, 2010

Medicago's H5N1 avian flu vaccine approved to enter phase II trial

Nov. 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...